THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER. (2026). PROBLEMS AND SOLUTIONS OF SCIENTIFIC AND INNOVATIVE RESEARCH, 3(1), 11-13. https://universalconference.us/index.php/pssir/article/view/6365